{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:27:17Z","timestamp":1791412037149,"version":"4.3.3"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.autrev.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T16:38:39Z","timestamp":1416242319000},"page":"254-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th\/To autoantigen"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Mahler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin J.","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.11.007_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1749-6632.2009.05127.x","article-title":"Epitope specificity and significance in systemic autoimmune diseases","volume":"1183","author":"Mahler","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.11.007_bb0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.autrev.2012.05.011","article-title":"Autoantibodies in systemic sclerosis","volume":"12","author":"Mehra","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.007_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/s10165-009-0155-3","article-title":"Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases","volume":"19","author":"Satoh","year":"2009","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0020","doi-asserted-by":"crossref","first-page":"494356","DOI":"10.1155\/2012\/494356","article-title":"The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases","volume":"2012","author":"Mahler","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0025","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/art.34380","article-title":"Prevalence and sociodemographic correlates of antinuclear antibodies in the United States","volume":"64","author":"Satoh","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0030","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.007_bb0035","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2007.01.013","article-title":"Novel aspects of autoantibodies to the PM\/Scl complex: clinical, genetic and diagnostic insights","volume":"6","author":"Mahler","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.007_bb0040","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0045","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/art.1780390712","article-title":"Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0050","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.3899\/jrheum.100316","article-title":"Anti-Th\/To are common antinucleolar autoantibodies in Italian patients with scleroderma","volume":"37","author":"Ceribelli","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0055","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1002\/art.10673","article-title":"Identity of the RNase MRP- and RNase P-associated Th\/To autoantigen","volume":"46","author":"Van Eenennaam","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1365-2249.2002.01991.x","article-title":"Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associations","volume":"130","author":"Van Eenennaam","year":"2002","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0065","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1002\/art.1780331210","article-title":"Autoantibody to Th ribonucleoprotein (nucleolar 7-2 RNA protein particle) in patients with systemic sclerosis","volume":"33","author":"Okano","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0070","first-page":"1600","article-title":"Anti-Th\/To-positivity in a cohort of patients with idiopathic pulmonary fibrosis","volume":"33","author":"Fischer","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0075","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jaut.2010.06.019","article-title":"Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells","volume":"35","author":"Wiik","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.11.007_bb0080","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/ard.61.9.842","article-title":"Differences in autoantibody response to Th\/To between systemic sclerosis and other autoimmune diseases","volume":"61","author":"Kuwana","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.007_bb0085","doi-asserted-by":"crossref","first-page":"R50","DOI":"10.1186\/ar4210","article-title":"Rpp25 is a major target of autoantibodies to the Th\/To complex as measured by a novel chemiluminescent assay","volume":"15","author":"Mahler","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0090","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3899\/jrheum.131450","article-title":"Autoantibodies to the Rpp25 component of the Th\/To complex are the most common antibodies in patients with systemic sclerosis without antibodies detectable by widely available commercial tests","volume":"41","author":"Mahler","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.autrev.2012.07.005","article-title":"Diagnostic accuracy and predictive value of extended autoantibody profile in systemic sclerosis","volume":"12","author":"Villalta","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.007_bb0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jim.2012.03.001","article-title":"Optimization and diagnostic performance of a single multiparameter lineblot in the serological workup of systemic sclerosis","volume":"379","author":"Bonroy","year":"2012","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.autrev.2014.11.007_bb0105","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1186\/ar3858","article-title":"A new immunoprecipitation-real time quantitative PCR assay for anti-Th\/To and anti-U3RNP antibody detection in systemic sclerosis","volume":"14","author":"Ceribelli","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0110","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1007\/s10067-011-1751-0","article-title":"Gender and ethnicity differences in the prevalence of scleroderma-related autoantibodies","volume":"30","author":"Krzyszczak","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0115","first-page":"127","article-title":"Prevalence and clinical profiles of \u201cautoantibody-negative\u201d systemic sclerosis subjects","volume":"86","author":"Hudson","year":"2013","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0120","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s001099900072","article-title":"Identification of an alpha-helical epitope region on the PM\/Scl-100 autoantigen with structural homology to a region on the heterochromatin p25beta autoantigen using immobilized overlapping synthetic peptides","volume":"78","author":"Bluthner","year":"2000","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.autrev.2014.11.007_bb0125","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1186\/ar3029","article-title":"Clinical and serological evaluation of a novel CENP-A peptide based ELISA","volume":"12","author":"Mahler","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0130","doi-asserted-by":"crossref","first-page":"R704","DOI":"10.1186\/ar1729","article-title":"Clinical evaluation of autoantibodies to a novel PM\/Scl peptide antigen","volume":"7","author":"Mahler","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.007_bb0140","doi-asserted-by":"crossref","first-page":"R172","DOI":"10.1186\/ar3495","article-title":"Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features","volume":"13","author":"Mierau","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0145","doi-asserted-by":"crossref","first-page":"R78","DOI":"10.1186\/ar2276","article-title":"Heterogeneity of autoantibodies in 100 patients with autoimmune myositis: insights into clinical features and outcomes","volume":"9","author":"Koenig","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2014.11.007_bb0150","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/art.10760","article-title":"A comparison between anti-Th\/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement","volume":"48","author":"Mitri","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0155","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1097\/BOR.0b013e3282e7d8f9","article-title":"Update on autoantibodies in systemic sclerosis","volume":"19","author":"Walker","year":"2007","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0160","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1002\/art.24038","article-title":"Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis","volume":"58","author":"Koenig","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.11.007_bb0165","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.autrev.2012.11.006","article-title":"The role of nail-videocapillaroscopy in early diagnosis of scleroderma","volume":"12","author":"Rossi","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.11.007_bb0170","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3899\/jrheum.110121","article-title":"Agreement with guidelines from a large database for management of systemic sclerosis: results from the Canadian Scleroderma Research Group","volume":"39","author":"Pope","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.11.007_bb0175","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1136\/annrheumdis-2011-200742","article-title":"Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database","volume":"71","author":"Meier","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.11.007_bb0180","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T18:31:28Z","timestamp":1538073088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S1568997214002791"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.11.007","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies to the mitochondrial RNA processing (MRP) complex also known as Th\/To autoantigen","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}